Shopping Cart
- Remove All
Your shopping cart is currently empty
PAT-1251 is an inhibitor of LOXL2 with IC50s of 10, 0.12, and 0.16 μM for the mouse, rat, and dog and can be used in studies about fibrotic diseases.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $66 | In Stock | |
| 5 mg | $160 | In Stock | |
| 10 mg | $255 | In Stock | |
| 25 mg | $409 | In Stock | |
| 50 mg | $571 | In Stock | |
| 100 mg | $803 | In Stock | |
| 200 mg | $1,070 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $176 | In Stock |
| Description | PAT-1251 is an inhibitor of LOXL2 with IC50s of 10, 0.12, and 0.16 μM for the mouse, rat, and dog and can be used in studies about fibrotic diseases. |
| Targets&IC50 | LOXL3 (human):1.17 μM, LOXL2 (dog):0.16 μM, LOXL2 (human):0.71 μM, LOXL2 (mouse):0.10 μM, LOXL2 (rat):0.12 μM |
| In vitro | PAT-1251 inhibits hLOXL2 and hLOXL3 with IC50s of 0.71 and 1.17 μM. PAT-1251 shows highly selective for LOXL2 over other amine oxidases, such as SSAO, DAO, MAO-A, and MAO-B with <10% inhibition at 10 μM[1]. |
| Synonyms | Lenumlostat, 2098884-52-5 |
| Molecular Weight | 399.34 |
| Formula | C18H17F4N3O3 |
| Cas No. | 2007885-39-2 |
| Smiles | NCc1cc(Oc2cccc(c2)C(=O)N2C[C@@H](O)[C@H](F)C2)nc(c1)C(F)(F)F |
| Relative Density. | 1.48 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 100 mg/mL (250.41 mM), Sonication is recommended. H2O: 100 mg/mL (250.41 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO/H2O
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.